MedTrace Logo

Drug-Drug Interaction Study of "CG100650" in Healthy Volunteers

NCT03775629 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2022-05-27

No results posted yet for this study

Summary

This is a randomized, open-label, multiple-dose, parallel, Phase 1 study to compare the pharmacokinetics and to evaluate Drug-Drug Interaction of "CG100650" in healthy volunteers.

Conditions

  • Healthy

Interventions

DRUG

Polmacoxib and Tramadol combination

Tramadol hydrochloride , Polmacoxib

DRUG

Polmacoxib

Polmacoxib

DRUG

Tramadol hydrochloride

Tramadol hydrochloride (HCl)

Sponsors & Collaborators

  • CrystalGenomics, Inc.

    lead INDUSTRY

Principal Investigators

  • Kyung-Sang Yu, Ph.D. · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2019-04-04
Completion
2019-04-10

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03775629 on ClinicalTrials.gov